Literature DB >> 11118619

Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation.

P C Zuzarte1, I K Farrance, P C Simpson, A G Wildeman.   

Abstract

The large tumor antigen (TAg) of simian virus 40 is able to transform cells through interactions with cellular proteins, notably p53 and Rb. Among the other proteins that form complexes with TAg is TEF-1, a transcription factor utilized by the viral enhancer to activate expression of the early gene which encodes TAg. We show that fibroblasts contain several alternately spliced TEF-1 mRNAs, the most abundant of which encodes a protein with an additional four amino acid exon compared to the database entry for Hela cell TEF-1. Transformation by TAg induces alternate splicing, producing a more abundant form lacking this exon and matching the published sequence. Splicing variants lacking this exon were detected in mouse pancreatic tumors and in cell lines derived from human pancreatic cancers, in contrast to a single isoform with the exon in normal mouse pancreas. A total of eight splice variants were identified, with the loss of the four amino acid exon typical of transformed cells. These and other data presented suggest that TAg 're-models' host cell transcription factors that are used early in viral infection, and thereby mimics an event that naturally occurs during transformation. The data indicate that TEF-1 alterations may be a hallmark feature of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118619     DOI: 10.1016/s0167-4781(00)00261-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  T' proteins influence JC virus biology.

Authors:  Richard J Frisque; Brigitte Bollag; Shiva K Tyagarajan; Lisa H Kilpatrick
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

2.  Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.

Authors:  Shohei Ikeda; Wataru Mizushima; Sebastiano Sciarretta; Maha Abdellatif; Peiyong Zhai; Risa Mukai; Nadezhda Fefelova; Shin-Ichi Oka; Michinari Nakamura; Dominic P Del Re; Iain Farrance; Ji Yeon Park; Bin Tian; Lai-Hua Xie; Mohit Kumar; Chiao-Po Hsu; Sakthivel Sadayappan; Hiroaki Shimokawa; Dae-Sik Lim; Junichi Sadoshima
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

3.  The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.

Authors:  William M Mahoney; Jeong-Ho Hong; Michael B Yaffe; Iain K G Farrance
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.

Authors:  Hélène C Laude; Barbara Jonchère; Eve Maubec; Agnès Carlotti; Eduardo Marinho; Benoit Couturaud; Martine Peter; Xavier Sastre-Garau; Marie-Françoise Avril; Nicolas Dupin; Flore Rozenberg
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

5.  Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.

Authors:  E G Ames; M J Lawson; A J Mackey; J W Holmes
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

Review 6.  An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors.

Authors:  André Landin-Malt; Ataaillah Benhaddou; Alain Zider; Domenico Flagiello
Journal:  Gene       Date:  2016-07-14       Impact factor: 3.688

7.  The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells.

Authors:  Binoy Appukuttan; Trevor J McFarland; Andrew Stempel; Jean B Kassem; Matthew Hartzell; Yi Zhang; Derek Bond; Kelsey West; Reid Wilson; Andrew Stout; Yuzhen Pan; Hoda Ilias; Kathryn Robertson; Michael L Klein; David Wilson; Justine R Smith; J Timothy Stout
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.